Epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome.
作者信息
Kahan A, Weber S, Amor B, Menkes C J
出版信息
Lancet. 1983 Mar 5;1(8323):538. doi: 10.1016/s0140-6736(83)92231-6.
PMID:6131248
Abstract
摘要
相似文献
1
Epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome.
Lancet. 1983 Mar 5;1(8323):538. doi: 10.1016/s0140-6736(83)92231-6.
2
Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.雷尼尔氏综合征患者间歇性输注依前列醇（前列环素）：一项双盲对照试验。
Lancet. 1983 Feb 12;1(8320):313-5. doi: 10.1016/s0140-6736(83)91624-0.
3
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).通过静脉输注前列环素（PGI2）治疗雷诺现象。
Br J Dermatol. 1982 Jan;106(1):81-9. doi: 10.1111/j.1365-2133.1982.tb00905.x.
4
Prostacyclin and the fibrinolytic system in ischemic vascular disease.缺血性血管疾病中的前列环素与纤维蛋白溶解系统
Thromb Res. 1983 Mar 15;29(6):655-60. doi: 10.1016/0049-3848(83)90220-7.
5
Raynaud's disease and prostacyclin.
Ann Intern Med. 1983 Feb;98(2):258. doi: 10.7326/0003-4819-98-2-258_3.
6
Epoprostenol in patients with Raynaud's disease.
Prostaglandins Leukot Essent Fatty Acids. 1988 Jul;33(1):23-7. doi: 10.1016/0952-3278(88)90118-4.
7
Infusion of prostacyclin (epoprostenol).输注前列环素（依前列醇）。
Lancet. 1982 Oct 2;2(8301):767. doi: 10.1016/s0140-6736(82)90949-7.
8
Successful treatment of Raynaud's Syndrome with prostacyclin.前列环素成功治疗雷诺氏综合征。
Thromb Haemost. 1981 Jun 30;45(3):255-6.
9
Prolonged remission in Raynaud's phenomenon after prostacyclin infusion.
Scand J Rheumatol. 1986;15(4):392-8. doi: 10.3109/03009748609098210.
10
Evidence for the Use of Epoprostenol to Treat Raynaud's Phenomenon With or Without Digital Ulcers.使用依前列醇治疗伴或不伴指端溃疡的雷诺现象的证据。
Ann Pharmacother. 2016 Dec;50(12):1060-1067. doi: 10.1177/1060028016660324. Epub 2016 Jul 26.
引用本文的文献
1
Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.
Arch Dermatol Res. 1985;277(4):323-5. doi: 10.1007/BF00509089.
Zotero 插件